Jade Biosciences (JBIO) Price & Analysis

Compare

157 Followers

JBIO Stock Chart & Stats

Day’s Range― - ―

52-Week Range$6.57 - $105.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)512.99K

Market Cap

$305.27M

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.46

Next Earnings

Aug 18, 2025

EPS Estimate

-0.43

Last Dividend Ex-Date

Apr 29, 2025

Dividend YieldN/A

Share Statistics

EPS (TTM)-12.10

Shares Outstanding32,235,928

10 Day Avg. Volume205,367

30 Day Avg. Volume512,992

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)0.00

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$15.67

Price Target Upside80.32% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering4

Jade Biosciences News

PremiumThe Fly

Jade Biosciences appoints Dahms as Chief Financial Officer

22d ago

JBIO

PremiumCompany Announcements

Jade Biosciences Signs Agreement with Patheon Biologics

22d ago

JBIO

PremiumThe Fly

Jade Biosciences upgraded to Buy from Neutral at Guggenheim

1M ago

JBIO

PremiumThe Fly

Jade Biosciences presents JADE101 preclinical data at ERA Congress

1M ago

JBIO

PremiumPre-Earnings

Is AVTE a Buy, Before Earnings?

2M ago

JBIO

PremiumRatings

Promising Future for Jade Biosciences: Buy Rating Backed by Innovative JADE101 and Experienced Leadership

2M ago

JBIO

PremiumCompany Announcements

Jade Biosciences Updates Corporate Presentation

2M ago

JBIO

PremiumThe Fly

Jade Biosciences initiated with an Outperform at Wedbush

3M ago

JBIO

See All JBIO News

See All News >

Bulls Say, Bears Say

Bulls Say

Drug EfficacyJADE101 shows an impressive half-life of 27-33 days for subcutaneous dosing, surpassing competitors and potentially leading to greater IgA reductions.

Leadership And ExpertiseJade Biosciences is led by a world-class team that previously sold its IgAN portfolio to Novartis for a substantial amount, indicating strong leadership and expertise.

Market PositionThere is excitement for immune-targeted therapies in IgAN, and JBIO is in a favorable position with an extended dosing profile and competitive advantages.

Bears Say

Market CompetitionPreclinical data at ERA will detail how '101 avoids the TMDD effect negatively impacting other anti-APRILs, highlighting the challenges competitors face.

Options Prices

Detailed Option Prices >

Ownership Overview

4.17%

Insiders

0.82%

Mutual Funds

― Other Institutional Investors

91.77% Public Companies and Individual Investors

Detailed Ownership Overview >

JBIO FAQ

What was Jade Biosciences, Inc.’s price range in the past 12 months?

Jade Biosciences, Inc. lowest stock price was $6.57 and its highest was $105.00 in the past 12 months.

What is Jade Biosciences, Inc.’s market cap?

Jade Biosciences, Inc.’s market cap is $305.27M.

When is Jade Biosciences, Inc.’s upcoming earnings report date?

Jade Biosciences, Inc.’s upcoming earnings report date is Aug 18, 2025 which is in 26 days.

How were Jade Biosciences, Inc.’s earnings last quarter?

Jade Biosciences, Inc. released its earnings results on May 14, 2025. The company reported -$12.1 earnings per share for the quarter, missing the consensus estimate of -$6.025 by -$6.075.

Is Jade Biosciences, Inc. overvalued?

According to Wall Street analysts Jade Biosciences, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Jade Biosciences, Inc. pay dividends?

Jade Biosciences, Inc. pays a Notavailable dividend of $2.4 which represents an annual dividend yield of N/A. See more information on Jade Biosciences, Inc. dividends here

What is Jade Biosciences, Inc.’s EPS estimate?

Jade Biosciences, Inc.’s EPS estimate is -0.43.

How many shares outstanding does Jade Biosciences, Inc. have?

Jade Biosciences, Inc. has 32,235,928 shares outstanding.

What happened to Jade Biosciences, Inc.’s price movement after its last earnings report?

Jade Biosciences, Inc. reported an EPS of -$12.1 in its last earnings report, missing expectations of -$6.025. Following the earnings report the stock price went down -1.987%.

Which hedge fund is a major shareholder of Jade Biosciences, Inc.?

Currently, no hedge funds are holding shares in JBIO

Jade Biosciences Stock Smart Score

Outperform

Fundamentals

Return on Equity

-59.01%

Trailing 12-Months

Asset Growth

-27.42%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Jade Biosciences, Inc.

Aerovate Therapeutics (AVTE) is a biotechnology company focused on developing innovative therapies for severe respiratory diseases. The company operates within the pharmaceutical and biotechnology sectors, specializing in the research and development of novel treatments aimed at addressing unmet medical needs in pulmonary arterial hypertension (PAH) and other serious conditions. Aerovate's core product pipeline includes AV-101, an inhaled dry powder formulation of imatinib, designed to improve the lives of patients suffering from PAH.

JBIO Stock 12 Month Forecast

Average Price Target

$15.67

▲(80.32%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","32":"$32","59":"$59","86":"$86","113":"$113"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$17.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$15.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,32,59,86,113],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2024","6":"May<br/>2024","9":"Aug<br/>2024","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.84,11.313846153846153,11.787692307692307,12.26153846153846,12.735384615384616,13.20923076923077,13.683076923076923,14.156923076923077,14.63076923076923,15.104615384615386,15.57846153846154,16.052307692307693,16.526153846153846,{"y":17,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.84,11.211538461538462,11.583076923076923,11.954615384615384,12.326153846153845,12.697692307692307,13.069230769230769,13.44076923076923,13.812307692307693,14.183846153846154,14.555384615384614,14.926923076923078,15.298461538461538,{"y":15.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.84,11.083076923076923,11.326153846153845,11.569230769230769,11.812307692307693,12.055384615384614,12.298461538461538,12.541538461538462,12.784615384615385,13.027692307692307,13.27076923076923,13.513846153846153,13.756923076923076,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":61.32,"date":1690848000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.91,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.09,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.34,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.14,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.44,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.2,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.81,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.22,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.54,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.2,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.84,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >